Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis sells skin drug to Meda for $420 mln
Reuters
Thursday, April 7, 2011 - 1:42pm
tags:
Meda, Novartis, Elidel
Analyst: J&J may need a $10B-plus deal
Fierce Pharma
Thursday, April 7, 2011 - 1:41pm
tags:
JNJ, M&A
Biotech: Top 3 Analyst Picks
Seeking Alpha
Thursday, April 7, 2011 - 1:39pm
tags:
Elan, Protalix BioTherapeutics, InterMune
How Many Patients Would Switch To Generics?
Pharmalot
Thursday, April 7, 2011 - 10:09am
tags:
generics
Biotech Catalysts for Q2 2011
Seeking Alpha
Thursday, April 7, 2011 - 10:09am
tags:
biotech, XenoPort, Titan, Raptor Pharmaceuticals, Adeona, Delcath
Inhibitex shares tumble in pre-market trading a day after company announces stock offering
Yahoo/AP
Thursday, April 7, 2011 - 10:07am
tags:
Inhibitex, stock offering
Valeant CEO Spurns Drug Research for Deals With Cephalon Fight
Bloomberg
Thursday, April 7, 2011 - 9:17am
tags:
Vertex Pharmaceuticals, R&D, M&A, Cephalon, Pharma CEOs, J. Michael Pearson
Cancer drug companies SuperGen, Astex to merge in cash, stock deal
Bizjournals.com
Thursday, April 7, 2011 - 9:15am
tags:
M&A, Astex, Supergen
FDA approves GlaxoSmithKline, XenoPort restless leg drug
Bizjournals.com
Thursday, April 7, 2011 - 9:14am
tags:
FDA, restless legs syndrome, GSK, XenoPort, Horizant
AstraZeneca’s Victory Highlights Difficulty Of Cancer Drug Development
Forbes
Wednesday, April 6, 2011 - 7:46pm
tags:
cancer, drug development, AstraZeneca, vandetanib, thyroid cancer
Merck Fails to Win FDA Approval on Gardasil Use in Older Women
Bloomberg
Wednesday, April 6, 2011 - 7:44pm
tags:
Merck, FDA, Gardasil, HPV
Breast-Cancer Link to Paxil Drug Category Found in Antidepressant Research
Bloomberg
Wednesday, April 6, 2011 - 7:40pm
tags:
antidepressants, SSRIs, breast cancer, Eli Lilly, Paxil, GSK, Prozac
Elan Up the Most in 3 Months After Positive Tysabri Comments
Bloomberg
Wednesday, April 6, 2011 - 7:36pm
tags:
Elan, Tysabri, bapineuzumab
Bullish Outlook For Novo Nordisk
Forbes/Zacks.com
Wednesday, April 6, 2011 - 7:34pm
tags:
Novo Nordisk
Is Celgene the Perfect Stock?
Motley Fool
Wednesday, April 6, 2011 - 7:32pm
tags:
Celgene
Millennium signs licensing pact with Sunesis Pharma
Pharmaceutical Business Review
Wednesday, April 6, 2011 - 8:40am
tags:
Sunesis, Millennium, pan-Raf, kinase inhibitors
AVI BioPharma: Recent Fund-Raising Not a Competitive Entry Point
Seeking Alpha
Wednesday, April 6, 2011 - 8:35am
tags:
AVI BioPharma
Optimer to Co-Market Dificid Drug With Cubist Pharmaceuticals
Bloomberg
Wednesday, April 6, 2011 - 8:18am
tags:
Dificid, Cubist Pharmaceuticals, Optimer, antibiotics, fidaxomicin
Novartis Aims to Resurrect ‘Zombie’ Drug After Four Years
Bloomberg
Wednesday, April 6, 2011 - 8:17am
tags:
Novartis, Europe, Joicela, painkillers, Prexige
Abbott Labs: 3 Reasons to Be Long-Term Bullish
Seeking Alpha
Wednesday, April 6, 2011 - 8:15am
tags:
Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.